AnalystsJim BirchenoughJim Birchenough's Stock Forecasts
AnalystsJim Birchenough
Sectors:
Analyst Ranking
Top 18%
#788 out of 4563 analysts
Average Return
+23.12%
Win Rate
33%6 out of 18
Risk vs Reward
Poor
Good
Jim Birchenough's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Juno Therapeutics IncJUNO | +275.53% | $23.05 | $86.56 | 2017-02-22 - 2018-02-22 | Buy |
Immunomedics IncIMMU | +219.52% | $26.18 | $83.65 | 2020-04-23 - 2020-09-14 | Strong Buy |
Turning Point Therapeutics IncTPTX | +112.62% | $35.75 | $76.01 | 2022-02-10 - 2022-08-16 | Strong Buy |
Five Prime Therapeutics IncFPRX | +111.11% | $18.00 | $38.00 | 2020-11-11 - 2021-04-15 | Strong Buy |
Kezar Life Sciences IncKZR | +108.59% | $3.26 | $6.80 | 2020-03-13 - 2021-03-12 | Strong Buy |
Jim Birchenough Analyst Color
Get additional color on Jim Birchenough's coverage of popular stocks
Jim Birchenough's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Regulus Therapeutics IncRGLS | 3 | Hold | $3.00 | +35.14% | Maintains | a month ago |
Crispr Therapeutics AgCRSP | 2 | Hold | $70.00 | +25.79% | Maintains | 2 months ago |
Sangamo Therapeutics IncSGMO | 1 | Hold | $1.00 | +102.84% | Downgrades | 6 months ago |
Global Blood Therapeutics IncGBT | 1 | Hold | $68.50 | N/A | Downgrades | 2 years ago |
Mei Pharma IncMEIP | 1 | Hold | $40.00 | N/A | Downgrades | 2 years ago |
Turning Point Therapeutics IncTPTX | 1 | Strong Buy | $85.00 | N/A | Maintains | 2 years ago |
Zymeworks IncZYME | 2 | Strong Buy | $48.00 | N/A | Maintains | 2 years ago |
Fate Therapeutics IncFATE | 1 | Strong Buy | $130.00 | N/A | Maintains | 3 years ago |
Precigen IncPGEN | 1 | Strong Buy | $14.00 | N/A | Initiates Coverage On | 3 years ago |
Gracell Biotechnologies IncGRCL | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 3 years ago |
Moderna IncMRNA | 2 | Hold | $145.00 | N/A | Maintains | 3 years ago |
Five Prime Therapeutics IncFPRX | 1 | Strong Buy | $34.00 | N/A | Upgrades | 3 years ago |
Bellicum Pharmaceuticals IncBLCM | 1 | Hold | $4.50 | N/A | Downgrades | 3 years ago |
Immunomedics IncIMMU | 4 | Hold | N/A | N/A | Downgrades | 4 years ago |
Avidity Biosciences IncRNA | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Intercept Pharmaceuticals IncICPT | 4 | Hold | $46.00 | N/A | Downgrades | 4 years ago |
Uniqure NvQURE | 1 | Hold | $56.00 | N/A | Downgrades | 4 years ago |
Regeneron Pharmaceuticals IncREGN | 1 | Strong Buy | $734.00 | N/A | Upgrades | 4 years ago |
Imv IncIMVIQ | 1 | Strong Buy | $85.00 | N/A | Upgrades | 4 years ago |
Gilead Sciences IncGILD | 2 | Hold | $87.00 | N/A | Downgrades | 4 years ago |
Celyad Oncology SaCYADY | 1 | Strong Buy | $20.00 | N/A | Maintains | 4 years ago |
Kezar Life Sciences IncKZR | 1 | Strong Buy | $18.00 | N/A | Maintains | 4 years ago |
Infinity Pharmaceuticals IncINFI | 2 | Hold | N/A | N/A | Downgrades | 5 years ago |
Array Technologies IncARRY | 1 | Buy | $33.00 | N/A | Maintains | 6 years ago |
Jounce Therapeutics IncJNCE | 1 | Hold | $10.00 | N/A | Maintains | 6 years ago |
Akcea Therapeutics IncAKCA | 3 | Buy | N/A | N/A | Upgrades | 6 years ago |
Immune Design CorpIMDZ | 1 | Hold | $10.00 | N/A | Maintains | 7 years ago |
Dimension Therapeutics IncDMTX | 1 | Hold | $6.00 | N/A | Maintains | 7 years ago |
Adaptimmune Therapeutics PLCADAP | 1 | Hold | N/A | N/A | Initiates Coverage On | 7 years ago |
Juno Therapeutics IncJUNO | 1 | Buy | N/A | N/A | Initiates Coverage On | 7 years ago |
Kite Pharma IncKITE | 1 | Hold | N/A | N/A | Initiates Coverage On | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.